(Epistemic status: Unsure on details. Some post-publication edits 5/1 to make this less strident.) I. There is a national shortage of buspirone. Buspirone is a 5HT-1 agonist used to control anxiety. Unlike most psychiatric drugs, it's in a class of its own – there are no other sole 5HT-1 agonists on the market. It's not a very strong medication, but it's safe, it's non-addictive, it's off-patent, and it works well for a subset of patients. Some of them have been on it for years. Now there's a national shortage. My patients can't get it, or have to go hunting from pharmacy to pharmacy until they find one that has it. I've told people find a source to stockpile a supply so they don't run out. It feels like we're living in the Soviet Union. How did this happen? The New York Times writes: The main reason for the buspirone shortage appears to be interrupted production at a Mylan Pharmaceuticals plant in Morgantown, W.Va., which produced about a third of the country's supply of the drug. The Food and Drug Administration had said the facility was dirty and that the company failed to follow quality control procedures.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other episodes from Astral Codex Ten Podcast
Transcribed and ready to explore now
Your Review: Joan of Arc
07 Aug 2025
Astral Codex Ten Podcast
Book Review: Selfish Reasons To Have More Kids
03 Jun 2025
Astral Codex Ten Podcast
Links For February 2025
11 Mar 2025
Astral Codex Ten Podcast
The Emotional Support Animal Racket
28 May 2024
Astral Codex Ten Podcast
The Psychopolitics Of Trauma
27 Jan 2024
Astral Codex Ten Podcast
Book Review: A Clinical Introduction To Lacanian Psychoanalysis
27 Apr 2022
Astral Codex Ten Podcast